Cutaneous B-Cell Pseudolymphoma Successfully Treated with Triamcinolone Acetonide
Keywords:Cutaneous B-Cell pseudolymphoma, Immunohistochemistry, Triamcinolone acetonide
BACKGROUND: Cutaneous pseudolymphoma (PSL) is a reactive polyclonal benign lymphoproliferative process in the skin that simulate cutaneous lymphomas clinically, histologically, or both, predominantly composed of either B-cells or T-cells, localized or disseminated. PSL clinically manifests as solitary nodules or plaque on the face. In cases where cutaneous PSL is suspected, the most crucial part is diagnosis, to differentiate benign or malignant lesion. Diagnosis required a combination of clinical, histopathological, and immunohistochemistry examination.
CASE REPORT: A 59-year-old man presented with asymptomatic erythematous plaque on her cheek for 6 months before. Histopathological examination revealed dense small lymphocytic infiltration forming lymphoid follicles with centrum germinativum that partially destructed skin appendice glands. Immunohistochemistry examination showed positive result on cluster of differentiation (CD)20 and CD3 staining. With domination of CD20 treatment: Patient was treated with intralesional injection of triamcinolone acetonide 10 mg/ml and showed satisfying result after 3 times injection.CONCLUSION: A cutaneous B-cell PSL in a 59-year-old man was diagnosed based on history and physical, histopathological, and also immunohistochemistry examination. Intralesional injection of 10 mg/ml triamcinolone acetonide gave satisfying result.
Plum Analytics Artifact Widget Block
Kerns ML, Anna L, Kang S, Fitzpatrick’s W, Kempf W, Stadler R, et al. Cutaneous pseudolymphoma. In: Kang S, Amagai M, Bruckner AL, Alexander H, Margolis DJ, McMichael AJ, et al. Fitzpatrick’s. 9th ed. 2019.
Terada T. Cutaneous pseudolymphoma: A case report with an immunohistochemical study. Int J Clin Exp Pathol. 2013;6(5):966-72. PMid:23638232
Miguel D, Peckruhn M, Elsner P. Treatment of cutaneous pseudolymphoma: A systematic review. Acta Derm Venereol. 2018;98(3):310-7. PMid:29136262
Shetty SK, Hegde U, Jagadish L, Shetty C. Pseudolymphoma versus lymphoma: An important diagnostic decision. J Oral Maxillofac Pathol. 2016;20(2):328. PMid:27601833
Bergman R. Pseudolymphoma and cutaneous lymphoma: Facts and controversies. Clin Dermatol. 2010;28(5):568-74. PMid:20797521
Koh WL, Tay YK, Koh MJ, Sim CS. Cutaneous pseudolymphoma occurring after traumatic implantation of a foreign red pigment. Singapore Med J. 2013;54(5):e100-1. PMid:23716159
Shashikumar B, Harish M, Katwe K, Kavya M. Cutaneous pseudolymphoma: An enigma. Clin Dermatol Rev. 2017;1:22.
Prabhu V, Shivani A, Pawar V. Idiopathic cutaneous pseudolymphoma: An enigma. Indian Dermatol Online J. 2014;5(2):224-6. PMid:24860772
Hussein MR. Cutaneous pseudolymphomas: Inflammatory reactive proliferations. Expert Rev Hematol. 2013;6(6):713-33. PMid:24191857
Magro CM, Daniels BH, Crowson AN. Drug induced pseudolymphoma. Semin Diagn Pathol. 2018;35(4):247-59. PMid:29361381
Bombonato C, Pampena R, Lallas A, Giovanni P, Longo C. Dermoscopy of lymphomas and pseudolymphomas. Dermatol Clin. 2018;36(4):377-88. PMid:30201147
Mitteldorf C, Kempf W. Cutaneous pseudolymphoma. Surg Pathol Clin. 2017;10(2):455-76. PMid:28477891
Mitteldorf C, Kempf W. Cutaneous pseudolymphoma-a review on the spectrum and a proposal for a new classification. J Cutan Pathol. 2020;47(1):76-97. PMid:31237707
Sasidharanpillai S, Aravindan K, Nobin B, Raghavan N, Nikhila P, Riyaz N. Phenytoin induced cutaneous B cell pseudolymphoma. Indian J Dermatol. 2015;60(5):522. PMid:26538730
How to Cite
Copyright (c) 2021 Tulus Dyah Anggraeni, Airin Nurdin, Farida Tabri, Faridha Ilyas (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All rights reserved.